Purchase Order 75F40124P00008
Award Date 11/15/23
Potential Completion Date 11/26/28
Potential Value $192K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for a preventive maintenance agreement on a BD LSRFortessa X-20 flow cytometer. The contract has a ceiling value of $186,838.20 and a period of performance through July 3, 2028. The contract was not set aside for small businesses. BD is a large, established medical technology manufacturer that has a long history of providing specialized flow cytometry...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for preventative and corrective maintenance services on a BD FACSCanto II flow cytometer and BD High Throughput Sampler. The contract has a base period plus four one-year option periods, with a total potential value of $99,837.60. The contract was not set aside for small businesses. BD, a large medical technology manufacturer, has an extensive portfolio of...
- The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
- This is a $85,180.56 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for pre-inspection and preventive maintenance services on a FACScelesta flow cytometry instrument. The contract does not have a set-aside designation, indicating it was competitively awarded. BD is a global medical technology company that provides a range of specialized instruments, reagents, and services to federal agencies, including the National...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD), a global medical technology manufacturer, for the preventative and corrective maintenance of a FACSCANTO II flow cytometer, computer workstation, and three lasers. The $85,991.40 contract has an ultimate completion date of September 25, 2025 and was awarded on July 28, 2021. The award is not associated with a set-aside program. BD has a long history of providing...
- This firm fixed price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Becton, Dickinson and Company (BD) for LSRFortessa maintenance services. The $219,675 contract has a ceiling value and a performance period ending on September 30, 2025. The award does not utilize a set-aside designation. BD, a global medical technology company, will provide maintenance services for the agency's LSRFortessa instruments, which are...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
- This is a firm fixed-price delivery order for $93,979.84 awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) to provide preventive maintenance and pre-inspection services for a BD Biosciences LSR Fortessa flow cytometer. The contract is under the GSA Scientific Equipment and Services schedule and does not have a set-aside designation. BD Biosciences is a division of the larger Becton, Dickinson and Company that specializes in flow cytometry, cell imaging,...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging, a civilian agency, to Becton, Dickinson And Company (BD) for maintenance and repair services on BD Biosciences flow cytometry instruments and associated systems. The $166,971.60 contract has an ultimate completion date of March 31, 2029. BD is a global medical technology company that provides a wide range of products and services to federal agencies, including the Department of Veterans Affairs, National...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The $111,231.00 contract is for the delivery of goods and services by BD's Biosciences division, which focuses on flow cytometry, cell imaging, and genomics technologies that support biomedical research and clinical applications. BD has a history of providing...